| Model Number |
1003382-13 |
| Medical Device Problem Code |
Activation Failure (3270)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
09/28/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
|
| |
|
Event or Problem Description
|
|
It was reported that the procedure was performed to treat a lesion with no calcification and no tortuosity in left main coronary artery.The 5.0 x 13 mm rx ultra 9-cell stent delivery system (sds) was advanced to the target lesion with no issues; however, during an attempt to deploy the stent, the stent did not deploy.The sds was removed without issue.A new sds was used in the procedure successfully.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
A visual and functional inspection was performed on the returned device.The reported activation failure including expansion failures/inflation issue was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported activation failure including expansion failures/inflation issue.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.Na.
|
| |
|
Search Alerts/Recalls
|